Table 4 NAT2 genotype frequency in AD cases and controls.
NAT2 GENOTYPE | AD CASES (N = 45) | CONTROLS (N = 63) | EXPECTED | OR (95% CI) |
|---|---|---|---|---|
2*4/2*4 | 3 (0.07) | 4 (0.06) | 0.04 | 1.00 |
2*4/2*5A | 1 (0.02) | 4 (0.06) | 0.01 | 0.33 (0.02, 4.74) |
2*4/2*5B | 6 (0.13) | 10 (0.16) | 0.17 | 0.80 (0.13, 4.87) |
2*4/2*6A | 6 (0.13) | 4 (0.06) | 0.13 | 2.00 (0.28, 14.20) |
2*4/2*7B | 1 (0.02) | 0 (0) | 0.01 | - |
2*5B/2*5B | 6 (0.13) | 8 (0.13) | 0.18 | 1.00 (0.16, 6.26) |
2*5B/2*5C | 1 (0.02) | 1 (0.02) | 0.01 | 1.33 (0.06, 31.12) |
2*5B/2*6A | 16 (0.36) | 25 (0.40) | 0.26 | 0.85 (0.17, 4.33) |
2*6A/2*6A | 5 (0.11) | 5 (0.08) | 0.10 | 1.33 (0.19, 9.31) |
2*5B/2*7B | 0 (0) | 1 (0.02) | 0.01 | - |
2*5C/2*7B | 0 (0) | 1 (0.02) | 0.00 | - |
Others | 0 (0) | 0 (0) | 0.08 | - |
TOTAL | 45 (1.00) | 63 (1.00) | 1.00 | - |